Stockhead’s Fraser Palamara sits down with Althea Group (ASX:AGH) CEO Josh Fegan to get the short end of the long story on the company’s latest news.

Althea is seeking a positive EBITDA for FY25 after restructuring its business during a time of change in the cannabis market.

The company also believes its on the road to success through rolling out a range of cannabis beverages in the US.

Tune in to hear Althea Group’s Josh Fegan on a new JV deal, the opportunity in cannabis beverages and more.

Read MoreCannabisCannabis StocksHealth

Featured Companies

You might be interested in